Clinical trials of medicinal products shall be conducted after an obligatory review of the ethical, moral, and legal aspects of the clinical trial programme by the Ethics Committees established and function at the healthcare facilities where clinical trials are conducted. The Model Regulations on the Ethics Committee shall be approved by the central executive authority in charge of shaping the state policy in the field of healthcare.